Value-based Healthcare - Global Strategic Business Report

The global market for Value-based Healthcare was valued at US$10.1 Billion in 2025 and is projected to reach US$30.8 Billion by 2032, growing at a CAGR of 17.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global 'Value-Based Healthcare' Market - Key Trends & Drivers Summarized

Why Is the Traditional Healthcare Model Giving Way to Value-Based Care?

The global healthcare industry is undergoing a significant transformation, pivoting away from volume-based models - where providers are paid per service - to value-based healthcare (VBHC), where payments are linked to patient outcomes and care quality. This shift is driven by the unsustainable rise in healthcare costs, fragmented care delivery, and suboptimal patient outcomes in fee-for-service systems. Value-based care realigns incentives by rewarding providers for efficiency, coordination, and measurable health improvements rather than the sheer quantity of services delivered. Payers, including private insurers and public health systems, are increasingly adopting bundled payments, shared savings programs, and outcome-based contracts to hold providers accountable. This evolution is also spurred by chronic disease prevalence, aging populations, and digital advancements that enable outcome tracking and risk stratification. VBHC empowers patients through personalized care pathways, enhances provider accountability, and fosters systemic efficiency, making it a cornerstone of next-generation healthcare reform efforts worldwide.

How Are Digital Technologies Enabling the Rise of Value-Based Healthcare?

Technology is the backbone of value-based healthcare, enabling real-time data sharing, outcome measurement, and patient engagement at scale. Electronic health records (EHRs), telemedicine, and mobile health applications have become essential tools in facilitating coordinated, continuous, and data-driven care. Advanced analytics platforms leverage big data to predict patient risk, monitor chronic disease progression, and personalize treatment plans. Artificial intelligence (AI) is being used to analyze large volumes of clinical and claims data, identify care gaps, and recommend evidence-based interventions. Remote patient monitoring (RPM) devices allow for proactive care management, particularly for high-risk patients with conditions like diabetes, hypertension, and heart failure. Interoperability among health IT systems is also improving, making it easier for multiple stakeholders - hospitals, payers, primary care physicians, and specialists - to collaborate effectively. These digital capabilities not only support care quality improvement but also make performance-based payment models viable and scalable across diverse healthcare systems.

Can Stakeholder Alignment and Policy Reform Drive Widespread Adoption?

The transition to value-based healthcare hinges on the collective alignment of diverse stakeholders - governments, payers, providers, pharmaceutical companies, and patients - toward shared health goals. Policymakers are playing a critical role by enacting regulations and incentives that support VBHC adoption. In the U.S., initiatives like the Medicare Shared Savings Program and Accountable Care Organizations (ACOs) have demonstrated early success in cost reduction and quality enhancement. Similarly, countries like Sweden, the Netherlands, and Singapore have incorporated VBHC principles into national health strategies. Pharmaceutical and medical device companies are also embracing value-based agreements that tie reimbursement to real-world effectiveness, rather than unit sales. Employers and insurers are demanding outcome-based care for their covered populations to manage long-term costs. Patient advocacy is growing stronger, demanding transparency, personalized care, and measurable outcomes. Education, trust-building, and data transparency remain crucial for overcoming resistance and establishing value-based frameworks as a norm rather than a niche.

What Is Fueling the Expansive Growth in the Value-Based Healthcare Market?

The growth in the value-based healthcare market is driven by several factors rooted in healthcare system inefficiencies, payer innovations, and changing patient expectations. Rising healthcare expenditures - without proportional gains in patient outcomes - have compelled stakeholders to seek more sustainable, performance-linked care models. The proliferation of chronic illnesses and multimorbidity requires long-term, coordinated care, which is better supported through VBHC frameworks. Increasing adoption of digital health technologies enables accurate measurement of health outcomes and cost metrics, making value-based reimbursement practical. Employers and private payers are advocating for value-based insurance designs that focus on preventive care and long-term health outcomes, thereby driving demand from the payer side. Meanwhile, patients are becoming more involved in their healthcare journeys, expecting cost transparency, treatment efficacy, and personalized experiences - all of which VBHC is structured to deliver. Government reforms and global health initiatives are further institutionalizing value-based approaches through policy support, pilot programs, and international best practice sharing. As these dynamics intensify, VBHC is transitioning from a theoretical model into a dominant paradigm poised to redefine healthcare delivery on a global scale.

Report Scope

The report analyzes the Value-based Healthcare market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Models (Pay for Performance, Patient-centered Medical Home, Shared Savings, Shared Risk, Bundled Payment, Capitation Models); Payer (Medicare & Medicare Advantage, Medicaid, Commercial); Providers (Home Healthcare, Institutional Care, Self-Care, Hospital Therapy)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Pay for Performance segment, which is expected to reach US$7.1 Billion by 2032 with a CAGR of a 16.2%. The Patient-centered Medical Home segment is also set to grow at 14.9% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $2.8 Billion in 2025, and China, forecasted to grow at an impressive 22.1% CAGR to reach $6.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Value-based Healthcare Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Value-based Healthcare Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Value-based Healthcare Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Aetna Inc., Anthem, Inc., Athenahealth, Baker Tilly US, LLP, Better Health Group and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Value-based Healthcare market report include:

• Aetna Inc.
• Anthem, Inc.
• Athenahealth
• Baker Tilly US, LLP
• Better Health Group
• Blue Cross and Blue Shield of Minnesota
• Cardinal Health
• Change Healthcare
• Cigna Healthcare
• Curation Health
• Deloitte
• Humana
• Kaiser Permanente
• Lumeris
• McKesson Corporation
• MVP Health Care
• Navvis Healthcare
• NXGN Management, LLC
• Signify Health, Inc.
• UnitedHealth Group

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.